1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with resveratrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baran, Y; Cakir, Z; Sahin, F; Saydam, G | 1 |
| Baran, Y; Kartal, M; Sahin, F; Saydam, G | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and resveratrol
| Article | Year |
|---|---|
The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.
Topics: Amino Alcohols; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Caspase 3; Cell Proliferation; Ceramides; Colorimetry; Drug Synergism; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Membrane Proteins; Morpholines; Neoplasm Proteins; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sphingolipids; Stilbenes; Tumor Suppressor Proteins | 2011 |
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Topics: Apoptosis; Ceramides; Down-Regulation; Glucosylceramides; Glucosyltransferases; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophospholipids; Morpholines; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; RNA, Neoplasm; Sphingosine; Stilbenes; Up-Regulation | 2011 |